2018
DOI: 10.1016/j.bbrc.2018.01.023
|View full text |Cite
|
Sign up to set email alerts
|

Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 56 publications
0
3
0
Order By: Relevance
“…Several studies have demonstrated that miR-34b was reduced or lost in a number of cancers, including breast cancer, epithelial ovarian cancer and Gastric Cancer [12][13][14]. The association between a polymorphism in miR-34b and risk of cancer was also reported in independent studies and metaanalyses [15,16].…”
Section: Introductionmentioning
confidence: 93%
“…Several studies have demonstrated that miR-34b was reduced or lost in a number of cancers, including breast cancer, epithelial ovarian cancer and Gastric Cancer [12][13][14]. The association between a polymorphism in miR-34b and risk of cancer was also reported in independent studies and metaanalyses [15,16].…”
Section: Introductionmentioning
confidence: 93%
“…Stated thus, a hypothesis can be made that miRNAs may participate in OC metastasis via modulating their target genes. Notably, emerging evidence has demonstrated the importance of the miRNA-mRNA interplay in the pathogenesis and metastasis of OC [12,13]. Therefore, differentially expressed miRNAs and mRNAs were screened from primary and metastatic tissues of OC using highthroughput sequencing technique.…”
mentioning
confidence: 99%
“…In other words, any changes in both chromosomes and the genes as amplification defects, translocation or deletion can result in abnormal changes in genomic miRNA copy numbers leading to the changes in normal regulatory functions of miRNAs [ 23 ]. Genome-wide association studies could discover many genes encoding miRNAs in cancer-related genomic regions that might be oncogene or have tumor-suppressing role [ 24 , 25 ]. As initially described by Teague in 2010, miR-125a and miR-125b are tumor suppressor miRNAs that are up-regulated in the endometriotic lesions and involve in controlling cell migration and invasion.…”
Section: Introductionmentioning
confidence: 99%